BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21872132)

  • 21. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M; Ihn H; Yamane K; Tamaki K
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatofibrosarcoma protuberans of the scalp, with fibrosarcomatous areas masquerading as epidermal inclusion cyst.
    Gupta B; Verma N; Khurana N; Kumar Jain S
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27389726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual presentation of dermatofibrosarcoma protuberans in a male patient's breast: a case report and review of the literature.
    Al Tarakji M; Toro A; Di Carlo I; Junejo K
    World J Surg Oncol; 2015 Apr; 13():158. PubMed ID: 25896773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
    Kovarik CL; Hsu MY; Cockerell CJ
    J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT.
    Bae SH; Lee JY
    Iran J Radiol; 2016 Apr; 13(2):e33916. PubMed ID: 27703659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermatofibrosarcoma protuberans recurring as a hybrid dermatofibrosarcoma/giant cell fibroblastoma in an adult: a case report.
    Warbrick-Smith J; Hollowood K; Birch J
    J Plast Reconstr Aesthet Surg; 2010 Nov; 63(11):e785-7. PubMed ID: 20655288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasolacrimal duct obstruction secondary to dermatofibrosarcoma protuberans.
    Bryar P; Sun R; Ebroon D
    Ophthalmology; 2004 Jul; 111(7):1398-400. PubMed ID: 15234144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases.
    Edelweiss M; Malpica A
    Am J Surg Pathol; 2010 Mar; 34(3):393-400. PubMed ID: 20139758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermatofibrosarcoma protuberans: clinicopathological aspects of an unusual cutaneous tumor.
    Korkolis DP; Liapakis IE; Vassilopoulos PP
    Anticancer Res; 2007; 27(3B):1631-4. PubMed ID: 17595787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late recurrence of dermatofibrosarcoma protuberans in the female breast: a case report.
    Swan MC; Banwell PE; Hollowood K; Goodacre TE
    Br J Plast Surg; 2005 Jan; 58(1):84-7. PubMed ID: 15629172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep dermatofibrosarcoma protuberans: a subcutaneous variant.
    Diaz-Cascajo C; Weyers W; Rey-Lopez A; Borghi S
    Histopathology; 1998 Jun; 32(6):552-5. PubMed ID: 9675595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dermatofibrosarcoma protuberans of the breast].
    Chargui R; Damak T; Khomsi F; Gamoudi A; Ben Hassouna J; Boussen H; Rahal K
    Tunis Med; 2006 Feb; 84(2):122-4. PubMed ID: 16755978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dermatofibrosarcoma protuberans: case report].
    Kozarev J; Cuk D
    Med Pregl; 1999; 52(1-2):71-3. PubMed ID: 10352509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.
    Minter RM; Reith JD; Hochwald SN
    J Surg Oncol; 2003 Mar; 82(3):201-8. PubMed ID: 12619065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis.
    Sabater-Marco V; Pérez-Vallés A; Berzal-Cantalejo F; Rodriguez-Serna M; Martinez-Diaz F; Martorell-Cebollada M
    Int J Dermatol; 2006 Jan; 45(1):59-62. PubMed ID: 16426380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic metastasis of dermatofibrosarcoma protuberans.
    Yokoyama Y; Murakami Y; Sasaki M; Morifuji M; Hayashidani Y; Kobayashi T; Sudo T; Sueda T
    J Gastroenterol; 2004 Aug; 39(8):798-800. PubMed ID: 15338376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatofibrosarcoma Protuberans of the Breast-a Rare Entity.
    Maji S; Paul MJ; Sen S
    Indian J Surg Oncol; 2018 Sep; 9(3):351-354. PubMed ID: 30287997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatofibrosarcoma protuberans with atrophic appearance at early stage of the tumor.
    Hanabusa M; Kamo R; Harada T; Ishii M
    J Dermatol; 2007 May; 34(5):336-9. PubMed ID: 17408444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.